In other studies, plasma levels of LCN2/matrix metallopeptidase 9 complex, MMP2, TIMP1, TIMP2 and TIMP3 were correlated to tumor size, lymph node involvement, tumor differentiation and prediction of tumor stage and T status in patients affected with HNSCC [24–26]. This evidence concerns the gene MMP2 and neoplasm.